Navigation Links
Asterias Biotherapeutics Announces Investor Briefing Conference Call and Webcast
Date:8/25/2014

MENLO PARK, Calif., Aug. 25, 2014 /PRNewswire/ -- Asterias Biotherapeutics, Inc. (OTCBB: ASTY), a leading biotechnology company in the emerging field of regenerative medicine, announced today that it will host an investor briefing conference call and slide presentation via webcast on Wednesday, August 27, 2014, at 4:30 p.m. EDT, 1:30 p.m. PDT.  At this briefing, Asterias management will review the Company's business strategy and product development pipeline.

For both "listen-only" participants and those participants who wish to take part in the question-and-answer portion of the call, the dial-in number in the U.S. is 877-407-8291. For participants outside the U.S., the dial-in number is 201-689-8345. To access the live webcast, go to http://www.wsw.com/webcast/cc/astb.

A replay of the conference call will be available for seven business days beginning about two hours after the conclusion of the live call.  The telephone dial-in number for U.S. participants is 877-660-6853. For participants outside the U.S., the replay dial-in number is 201-612-7415. An archived webcast will also be available for 30 days, and may be accessed at http://www.wsw.com/webcast/cc/astb.

About Asterias Biotherapeutics

Asterias' core technologies center on stem cells capable of becoming all of the cell types in the human body, a property called pluripotency. Asterias plans to develop therapies based on pluripotent stem cells to treat diseases or injuries in a variety of medical fields having major unmet needs and without adequate therapies available. Asterias' initial focus is on two clinical stage programs including oligodendrocyte progenitor cells (AST-OPC1) for spinal cord injuries and antigen-presenting allogeneic dendritic cells (AST-VAC2) for lung cancer.

In October of 2013, Asterias acquired the cell therapy
'/>"/>

SOURCE Asterias Biotherapeutics, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Asterias Biotherapeutics Appoints Two Independent Directors and Announces Completion of Series A Common Stock Distribution
2. Oxford BioTherapeutics Appoints Senior Industry Leader to Head its New Clinical Development Operations in Basel, Switzerland
3. Actinium Pharmaceuticals Inc. Pays Regulatory Milestone to Abbott Biotherapeutics Corp.
4. Healthpoint Biotherapeutics Initiates Phase III Study of Unique Investigational Cell-Based Therapy for Venous Leg Ulcers
5. Caliber and ImmunGene Launch Valor Biotherapeutics, a Joint Venture to Develop Antibody-Interferon Fusion Therapeutics to Treat Cancers
6. Northwest Biotherapeutics Announces Public Offering of Common Stock and Warrants, and Listing on NASDAQ
7. Northwest Biotherapeutics, Inc. Announces Full Exercise of Over- Allotment Option
8. iBio And Caliber Biotherapeutics Establish License And Collaboration Relationship
9. The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients
10. Northwest Biotherapeutics Announces Registered Direct Offering
11. Chrysalis BioTherapeutics, Inc., Receives $1.5m from the National Cancer Institute to Mitigate Radiotherapy-Induced Brain Tissue Damage
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... Redwood Pharma AB has entered into a ... both the US and China , ... hydrogel technology in its lead chronic Dry Eye therapeutic ... technology offers many unique competitive benefits. At lower temperatures, ... low concentrations of polymer the system can be transitioned ...
(Date:7/2/2015)... , July 2, 2015 ResMed Inc. (NYSE: ... quarter and fiscal year ended June 30, 2015 results on ... market close. A press release with ResMed,s results will be ... will host a webcast to discuss operating results and future ... at 1:30 p.m. US Pacific Time and the live webcast ...
(Date:7/2/2015)... , July 2, 2015 Roche,s ... conspicuously high-growth market segment in hematology testing, according ... said that Roche,s recent unveiling of its Bloodhound digital ... cobas m 511 hematology analyzer – ... capture growth enjoyed by current leader CellaVision, but ...
Breaking Medicine Technology:Redwood Pharma Licenses Novel Hydrogel Drug Delivery Technology From Broda Technologies 2ResMed to Announce Fourth Quarter and Fiscal Year-End 2015 Results 2Kalorama: With Bloodhound, Roche Closes in on High-Growth Hematology Segment 2Kalorama: With Bloodhound, Roche Closes in on High-Growth Hematology Segment 3
(Date:7/3/2015)... ... 03, 2015 , ... On June 30th SEO authority and ... system called "Page One Engine" . The program, which has been hailed ... from several well-known marketers. HonestyFirstReviews.com's Tiffany Hendricks has joined the party, publishing an ...
(Date:7/3/2015)... ... 2015 , ... Scientists at several top US cancer centers believe they now ... Click here to read the complete story , just posted on the Surviving ... Medical Center, and New York University exposed mice with a mutation on the tumor ...
(Date:7/3/2015)... , ... July 03, 2015 , ... ... to healthcare providers, has been retained to lead a national president recruitment ... search firms in the healthcare industry, B. E. Smith has recently placed more ...
(Date:7/3/2015)... ... July 03, 2015 , ... ... on June 25, 2015 at 1:00pm. The Association welcomed speaker C. Daniel McGillicuddy ... injured bicyclists and practical points of investigating these types of cases. , Each ...
(Date:7/3/2015)... ... , ... Talcum powder attorneys representing clients in national lawsuits announce the launch ... website. Just as the previous version did, the new website will serve as a ... ovarian cancer warning information. The site is routinely updated with news articles on talcum ...
Breaking Medicine News(10 mins):Health News:Page One Engine - Review Of Dori Friend's SEO Training Course Released 2Health News:Study Finds Small Amounts of Asbestos May Trigger Mesothelioma in People with Genetic Mutation, According to Surviving Mesothelioma 2Health News:Regional Care, Inc. Retains B. E. Smith to Recruit New President 2Health News:Regional Care, Inc. Retains B. E. Smith to Recruit New President 3Health News:Attorney from William Mattar Leads Discussion on Bicycle Accidents 2Health News:Talcum Powder Lawsuit News: Cancer Attorneys Launch Updated Mobile Site 2Health News:Talcum Powder Lawsuit News: Cancer Attorneys Launch Updated Mobile Site 3
... 21 Barr Pharmaceuticals, Inc. (NYSE: BRL ) ... to them relating to the acquisition of Barr by Teva ... , "Today,s vote demonstrated the ... Bruce L. Downey, Barr,s Chairman and CEO. "We are pleased ...
... a statewide survey, 33 physicians credentialed to practice at the Texas ... Texas Monthly in its 2008 annual listing of " ... year, the publishers of Texas Monthly work with Key ... the state of Texas to ask, "If you needed medical care, ...
... Nov. 21 Innerscope Research(TM), a revolutionary,biometric media ... the appointment of three executives who will strengthen ... , The ... of experience,include Geoffrey Gill as Chief Financial Officer ...
... Three Minnesotans who successfully,quit smoking will receive big prizes during ... 24 at the Xcel Energy Center. The winners,were participants in ... QUITPLAN(R) Services. , The ... runners-up,will get $1,000 gift cards from Gander Mountain. , ...
... needed less pain meds, study found , , FRIDAY, Nov. ... the amount of pain-killing medication requested by women during ... expectant mothers. , Half the women were assigned ... during their pregnancy, while the other half acted as ...
... cardiovascular disease are not given adequate drug therapy. This is ... of Deutsches rzteblatt International ( Dtsch Arztebl Int ... German results of this prospective, one-year survey. , 512 doctors ... patients in all, of whom 89.2% suffered from one or ...
Cached Medicine News:Health News:Barr Shareholders Approve Pending Teva Acquisition 2Health News:Barr Shareholders Approve Pending Teva Acquisition 3Health News:Barr Shareholders Approve Pending Teva Acquisition 4Health News:Annual List of 'Super Doctors' Features 33 Texas Institute for Surgery Physicians 2Health News:Innerscope Research Strengthens Management Team With Three Executive Appointments 2Health News:Lucky Quitters to Receive Big Money in Stop-Smoking Contest 2Health News:Aquarobics May Help Ease Labor 2
... The OTF5000 represents the new style ... long-established and reliable OTF/AS cryostat, the ... systems in the ever-reliable and powerful ... options plus money-saving package deals makes ...
... Leica TP1020 product family are semi-enclosed tissue ... combination of approved technology with modern and ... maximum safety for tissues at all stages ... based on proven precision mechanics in conjunction ...
... A unique sliding microtome with ... during return travel. Maintenance-free precision cross ... specimens and specialty applications in biological, ... up to 155 x 90 mm ...
... face-lifted Leica RM2125 microtome comes in two ... Leica RM2125 RT. All RM2125 versions are ... debris entering the precision micrometer feeding system. ... two-step trimming function and specimen retraction as ...
Medicine Products: